NEW YORK, NY / ACCESSWIRE / February 08, 2016 / Overlooked stocks often create the best value and best return on investment. Find out how to profit by signing up today on ValueInvestment.com at:

http://ValuableInvestment.com

ValuableInvestment.com trade alerts for today covers these potentially profitable equities in the Medical Laboratories and Research industry: Agilent Technologies Inc. (NYSE: A), Exact Sciences Corporation (NASDAQ: EXAS), Thermo Fisher Scientific Inc. (NYSE: TMO), and Alere Inc. (NYSE: ALR). Do not miss out and register with us for the free trade alerts at:

http://ValuableInvestment.com/Register

On Friday, February 05, 2016, the NASDAQ Composite ended at 4,363.14, down 3.25%, the Dow Jones Industrial Average lost 1.29%, to finish the day at 16,204.97, and the S&P 500 closed at 1,880.05, down 1.85%.

Shares in Agilent Technologies Inc. ended Friday's session 3.69% lower at $36.04. The stock reported a trading volume of 4.42 million shares, above its three months average volume of 3.05 million shares. Shares of the company traded at a PE ratio of 27.51. The company is trading 8.97% below its 50-day moving average and 7.00% below its 200-day moving average. Moreover, shares of Agilent Technologies Inc. have a Relative Strength Index (RSI) of 36.16. Join our members and like them get free access to our trade alerts on A at:

http://valuableinvestment.com/Agilent

A simple yet effective way to find value is to focus on low debt to equity and a solid return on equity number. We have discovered a few such companies that you can be accessed by clicking here at:

http://valuableinvestment.com/FreeAlerts

Exact Sciences Corp.'s stock lost 5.28%, to close the day at $6.28. The stock recorded a trading volume of 1.53 million shares, below its three months average volume of 2.02 million shares. The company's shares are trading 21.63% below their 50-day moving average. Additionally, Exact Sciences Corp. has an RSI of 39.28. Sign up for your trade alert on EXAS at:

http://valuableinvestment.com/EXAS

On Friday, shares in Thermo Fisher Scientific Inc. recorded a trading volume of 4.17 million shares, higher than their three months average volume of 1.97 million shares. The stock ended the day 3.62% lower at $123.18. Shares of the company traded at a PE ratio of 24.99. The company is trading below its 50-day and 200-day moving averages by 9.54% and 6.14%, respectively. Furthermore, shares of Thermo Fisher Scientific Inc. have an RSI of 35.20. Register for free on ValuableInvestment.com and activate your trade alert on TMO at:

http://valuableinvestment.com/TMO

Alere Inc.'s stock finished Friday's session 0.62% lower at $53.20. A total of 4.34 million shares were traded, which was above its three months average volume of 1.86 million shares. Over the last one month and the previous three months, Alere Inc.'s shares have gained 37.01% and 13.68%, respectively. Additionally, the stock has surged 30.23% in the past one year. The company's shares are trading above their 50-day and 200-day moving averages by 32.24% and 12.38%, respectively. Alere Inc.'s stock has an RSI of 74.76. Trade Alert on ALR is available for free at:

http://valuableinvestment.com/ALR

--

About ValuableInvestment.com:

Valuable Investment was founded in 2006 and has been successfully alerting investors and shareholders of the most profitable ways to earn a living on Wall Street. A decade is a very long time so we must be doing something right. We encourage everyone to come and try our strategy and see how we have been changing the foundation of research for years.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.

NO WARRANTY

ValuableInvestment.com, the Author, the Reviewer, and the Sponsor (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither valuableinvestment.com nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://valuableinvestment.com/

RESTRICTIONS

ValuableInvestment.com is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press@valuableinvestment.com

SOURCE: ValuableInvestment.com